199 related articles for article (PubMed ID: 23892238)
1. Comparative effectiveness of fish oil versus fenofibrate, gemfibrozil, and atorvastatin on lowering triglyceride levels among HIV-infected patients in routine clinical care.
Muñoz MA; Liu W; Delaney JA; Brown E; Mugavero MJ; Mathews WC; Napravnik S; Willig JH; Eron JJ; Hunt PW; Kahn JO; Saag MS; Kitahata MM; Crane HM
J Acquir Immune Defic Syndr; 2013 Nov; 64(3):254-60. PubMed ID: 23892238
[TBL] [Abstract][Full Text] [Related]
2. Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186.
Gerber JG; Kitch DW; Fichtenbaum CJ; Zackin RA; Charles S; Hogg E; Acosta EP; Connick E; Wohl D; Kojic EM; Benson CA; Aberg JA
J Acquir Immune Defic Syndr; 2008 Apr; 47(4):459-66. PubMed ID: 17971707
[TBL] [Abstract][Full Text] [Related]
3. Fibrates and fish oil, but not corn oil, up-regulate the expression of the cholesteryl ester transfer protein (CETP) gene.
Raposo HF; Patrício PR; Simões MC; Oliveira HC
J Nutr Biochem; 2014 Jun; 25(6):669-74. PubMed ID: 24746832
[TBL] [Abstract][Full Text] [Related]
4. Over-the-counter fish oil use in a county hospital: Medication use evaluation and efficacy analysis.
Tatachar A; Pio M; Yeung D; Moss E; Chow D; Boatright S; Quinones M; Mathew A; Hulstein J; Adams-Huet B; Ahmad Z
J Clin Lipidol; 2015; 9(3):326-33. PubMed ID: 26073390
[TBL] [Abstract][Full Text] [Related]
5. Rhabdomyolysis after taking atorvastatin with gemfibrozil.
Duell PB; Connor WE; Illingworth DR
Am J Cardiol; 1998 Feb; 81(3):368-9. PubMed ID: 9468088
[TBL] [Abstract][Full Text] [Related]
6. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
Breuer HW
Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
[TBL] [Abstract][Full Text] [Related]
7. Insulin therapy for a non-diabetic patient with severe hypertriglyceridemia.
Jabbar MA; Zuhri-Yafi MI; Larrea J
J Am Coll Nutr; 1998 Oct; 17(5):458-61. PubMed ID: 9791843
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia.
Milionis HJ; Papakostas J; Kakafika A; Chasiotis G; Seferiadis K; Elisaf MS
J Clin Pharmacol; 2003 Aug; 43(8):825-30. PubMed ID: 12953339
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy of atorvastatin and micronized fenofibrate in the treatment of mixed hyperlipidemia.
Bairaktari ET; Tzallas CS; Tsimihodimos VK; Liberopoulos EN; Miltiadous GA; Elisaf MS
J Cardiovasc Risk; 1999 Apr; 6(2):113-6. PubMed ID: 10353071
[TBL] [Abstract][Full Text] [Related]
10. Cumulative non-HDL-cholesterol burden in patients with hypertriglyceridemia receiving long-term fibrate therapy: Real life data from a lipid clinic cohort.
Kayıkçıoğlu M; Shahbazova S; İbrahimov F; Can LH
Turk Kardiyol Dern Ars; 2020 Jun; 48(4):359-367. PubMed ID: 32519982
[TBL] [Abstract][Full Text] [Related]
11. Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia.
Frost RJ; Otto C; Geiss HC; Schwandt P; Parhofer KG
Am J Cardiol; 2001 Jan; 87(1):44-8. PubMed ID: 11137832
[TBL] [Abstract][Full Text] [Related]
12. Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients.
Lemieux I; Salomon H; Després JP
Ann Med; 2003; 35(6):442-8. PubMed ID: 14572169
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia.
Hogue JC; Lamarche B; Deshaies Y; Tremblay AJ; Bergeron J; Gagné C; Couture P
Metabolism; 2008 Feb; 57(2):246-54. PubMed ID: 18191056
[TBL] [Abstract][Full Text] [Related]
14. Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial.
Davidson M; Rosenson RS; Maki KC; Nicholls SJ; Ballantyne CM; Setze C; Carlson DM; Stolzenbach J
Cardiovasc Drugs Ther; 2012 Aug; 26(4):349-58. PubMed ID: 22622962
[TBL] [Abstract][Full Text] [Related]
15. Effects of micronized fenofibrate versus atorvastatin in the treatment of dyslipidaemic patients with low plasma HDL-cholesterol levels: a 12-week randomized trial.
Després JP; Lemieux I; Salomon H; Delaval D
J Intern Med; 2002 Jun; 251(6):490-9. PubMed ID: 12028504
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia.
Giral P; Bruckert E; Jacob N; Chapman MJ; Foglietti MJ; Turpin G
Atherosclerosis; 2001 Feb; 154(2):421-7. PubMed ID: 11166775
[TBL] [Abstract][Full Text] [Related]
18. Effect of gemfibrozil and fenofibrate on the pharmacokinetics of atorvastatin.
Whitfield LR; Porcari AR; Alvey C; Abel R; Bullen W; Hartman D
J Clin Pharmacol; 2011 Mar; 51(3):378-88. PubMed ID: 20413454
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of atorvastatin and gemfibrozil, alone and in low dose combination, in the treatment of diabetic dyslipidemia.
Wägner AM; Jorba O; Bonet R; Ordóñez-Llanos J; Pérez A
J Clin Endocrinol Metab; 2003 Jul; 88(7):3212-7. PubMed ID: 12843167
[TBL] [Abstract][Full Text] [Related]
20. Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT).
Malik J; Melenovsky V; Wichterle D; Haas T; Simek J; Ceska R; Hradec J
Cardiovasc Res; 2001 Nov; 52(2):290-8. PubMed ID: 11684077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
